Inhibition of AKT after LMP1 knockdown enhances tumor cell sensitivity to cisplatin; and LMP1 regulates mitochondrial dynamic protein‐related protein 1 (Drp1) to promote NPC cell survival and cisplatin resistance (Mei et al, 2007; Xie et al, 2020). The gene discussed is PDLIM7; the disease is neoplasm.